August 25, 2009
By:Reflector
The presence of a high-flying Obama administration insider at the upcoming Swedish life sciences summit is just one indication of the seriousness with which the country taking its EU presidency.
 |
August 11, 2009
By:Reflector
Reflector reports on how Belgium's best intentions have backfired on its generics manufacturers.
|
July 28, 2009
By:Reflector
The climax of the antitrust investigation instigated with all guns blazing by EC commissioner Neelie Kroes last year has been a whimper, not a bang. Reflector reports.
|
July 14, 2009
By:Reflector
As the major companies grapple with various crises from patent expirations to regulatory clampdowns, Reflector looks at how small pharma is coming into its own.
|
April 28, 2009
By:Reflector
News of the potential Solvay sale has sent the company's stock soaring, but is it good news for Belgium? Reflector reports.
|
April 14, 2009
By:Reflector
Reflector points to a number of recent alarm signals that have seen European pharma move further towards dangerous territory.
|
March 31, 2009
By:Reflector
Reflector ponders recent events in the battle against counterfeit drugs.
|
March 17, 2009
By:Reflector
Reflector ponders the growing gap between the US and Europe's vision for the future of drug marketing.
|
February 24, 2009
By:Reflector
Reflector welcomes the signs of EU agreement on encouraging the development of rare disease treatments.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
